Amalgamated Bank’s Eli Lilly LLY Stock Holding History

Amalgamated Bank’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$196M	Sell	163,154 -4,152	-2%	-$4.24M	1.35%	11
2026 Q1	$154M	Sell	167,306 -5,784	-3%	-$5.86M	1.18%	11
2025 Q4	$186M	Sell	173,090 -3,474	-2%	-$3.32M	1.34%	10
2025 Q3	$135M	Buy	176,564 +3,829	+2%	+$2.85M	0.96%	13
2025 Q2	$135M	Buy	172,735 +2,573	+2%	+$2M	1.04%	13
2025 Q1	$141M	Buy	170,162 +3,788	+2%	+$3.15M	1.2%	11
2024 Q4	$128M	Sell	166,374 -8,886	-5%	-$7.36M	1.05%	12
2024 Q3	$155M	Buy	175,260 +556	+0.3%	+$500K	1.28%	10
2024 Q2	$158M	Sell	174,704 -1,569	-0.9%	-$1.26M	1.35%	8
2024 Q1	$137M	Sell	176,273 -26,108	-13%	-$18.6M	1.17%	9
2023 Q4	$118M	Sell	202,381 -11,119	-5%	-$6.49M	0.94%	13
2023 Q3	$115M	Sell	213,500 -19,286	-8%	-$9.94M	0.98%	12
2023 Q2	$109M	Sell	232,786 -5,341	-2%	-$2.24M	0.88%	14
2023 Q1	$81.8M	Buy	238,127 +19,114	+9%	+$6.45M	0.7%	19
2022 Q4	$80.1M	Sell	219,013 -11,578	-5%	-$4.11M	0.71%	18
2022 Q3	$74.6M	Buy	230,591 +17,720	+8%	+$5.61M	0.72%	18
2022 Q2	$69M	Sell	212,871 -13,536	-6%	-$4.06M	0.64%	21
2022 Q1	$64.8M	Buy	226,407 +5,477	+2%	+$1.41M	0.5%	25
2021 Q4	$61M	Buy	220,930 +32,176	+17%	+$8.16M	0.45%	34
2021 Q3	$43.6M	Sell	188,754 -8,662	-4%	-$2.14M	0.37%	43
2021 Q2	$45.3M	Buy	197,416 +146,177	+285%	+$29.4M	0.36%	43
2021 Q1	$9.57M	Sell	51,239 -2,462	-5%	-$482K	0.36%	43
2020 Q4	$9.07M	Sell	53,701 -306	-0.6%	-$45.7K	0.34%	44
2020 Q3	$7.99M	Sell	54,007 -2,230	-4%	-$345K	0.35%	47
2020 Q2	$9.23M	Sell	56,237 -86,147	-61%	-$13.2M	0.43%	38
2020 Q1	$19.8M	Sell	142,384 -3,872	-3%	-$532K	0.48%	38
2019 Q4	$19.2M	Buy	146,256 +3,150	+2%	+$365K	0.35%	54
2019 Q3	$16M	Buy	143,106 +28,854	+25%	+$3.21M	0.34%	57
2019 Q2	$12.7M	Sell	114,252 -10,951	-9%	-$1.29M	0.3%	61
2019 Q1	$16.2M	Sell	125,203 -5,625	-4%	-$684K	0.39%	50
2018 Q4	$15.1M	Sell	130,828 -4,599	-3%	-$514K	0.43%	42
2018 Q3	$14.5M	Sell	135,427 -4,945	-4%	-$494K	0.36%	56
2018 Q2	$12M	Sell	140,372 -2,658	-2%	-$218K	0.29%	63
2018 Q1	$11.1M	Buy	143,030 +14,002	+11%	+$1.13M	0.29%	65
2017 Q4	$10.9M	Buy	129,028 +11,312	+10%	+$962K	0.29%	61
2017 Q3	$10.1M	Buy	117,716 +2,586	+2%	+$212K	0.31%	56
2017 Q2	$9.47M	Buy	115,130 +41,247	+56%	+$3.37M	0.31%	54
2017 Q1	$6.21M	Sell	73,883 -31,797	-30%	-$2.55M	0.31%	54
2016 Q4	$7.77M	Buy	105,680 +18,427	+21%	+$1.37M	0.35%	51
2016 Q3	$7M	Buy	87,253 +128	+0.1%	+$10.2K	0.41%	43
2016 Q2	$7.02M	Buy	87,125 +48,272	+124%	+$3.63M	0.41%	46
2016 Q1	$2.8M	Buy	38,853 +9,240	+31%	+$699K	0.27%	57
2015 Q4	$2.5M	Sell	29,613 -7,521	-20%	-$624K	0.31%	50
2015 Q3	$3.11M	Buy	37,134 +1,363	+4%	+$115K	0.33%	50
2015 Q2	$2.99M	Buy	35,771 +4,482	+14%	+$342K	0.29%	53
2015 Q1	$2.27M	Buy	31,289 +7,948	+34%	+$566K	0.28%	68
2014 Q4	$1.61M	Sell	23,341 -3,862	-14%	-$261K	0.25%	74
2014 Q3	$1.76M	Buy	27,203 +160	+0.6%	+$10.1K	0.26%	70
2014 Q2	$1.68M	Buy	27,043 +2,675	+11%	+$160K	0.25%	77
2014 Q1	$1.43M	Sell	24,368 -473	-2%	-$26.4K	0.25%	77
2013 Q4	$1.27M	Sell	24,841 -238	-0.9%	-$11.9K	0.22%	83
2013 Q3	$1.26M	Sell	25,079 -595	-2%	-$31.1K	0.41%	74
2013 Q2	$1.26M	Buy	+25,674	New	+$1.4M	0.46%	67

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Amalgamated Bank's LLY Position: Q2 2026 in Review

Amalgamated Bank reduced its Eli Lilly (LLY) stake by 2.5% in Q2 2026, selling an estimated $4.24M and leaving 163,154 shares worth $196M. The position accounts for 1.35% of the portfolio, ranked #11.

Amalgamated Bank first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 3,039 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Amalgamated Bank held 163,154 shares of Eli Lilly worth $196M as of Q2 2026.
Amalgamated Bank sold 4,152 Eli Lilly shares in Q2 2026, an estimated $4.24M.
Eli Lilly made up 1.35% of Amalgamated Bank's portfolio in Q2 2026, its #11 holding.
Amalgamated Bank first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
3,039 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.